Albuterol Use in Children Hospitalized with Human Metapneumovirus Respiratory Infection

Table 2

Characteristics of patients hospitalized with human metapneumovirus infection stratified by receipt of albuterol.

Characteristic	Albuterol ()	No albuterol ()	value
	Number (%)	Number (%)
Age (months)	18 (IQR 9–46)	15 (IQR 6–44)	0.29
Female gender	49 (35%)	33 (51%)	0.03
CMC (nonasthma)	42 (30%)	12 (18%)	0.09
CMC (asthma)	60 (42%)	4 (6%)	<0.001
Admission diagnosis			<0.001
Asthma exacerbation	28 (20%)	0
Acute respiratory infection	101 (71%)	43 (66%)
Seizure	3 (2%)	3 (5%)
Vaso-occlusive crisis	6 (4%)	2 (3%)
Other	4 (3%)	17 (26%)
Supplemental oxygen	94 (66%)	20 (31%)	<0.001
Hospital LOS (days)	3 (IQR 2–5)	3 (IQR 2–5)	0.18
Viral coinfection	30 (21%)	13 (20%)	0.85
Mortality	4 (3%)	0	0.31

IQR: interquartile range; CMC: chronic medical condition; LOS: length of stay.